The ki-Pot1aR117C mouse constitutes a potential pre-clinical mouse model for LFL syndrome presenting with high angiosarcoma incidence that could provide in the future a very useful tool for the study of treatments for these tumors. This evidence concerns the gene PSME3 and angiosarcoma.